Santra Gouranga
Department of Medicine, Midnapore Medical College, Paschim Medinipur, West Bengal, India.
Indian J Pharmacol. 2015 Nov-Dec;47(6):600-4. doi: 10.4103/0253-7613.169573.
Nonadherence to cardiovascular medicines is a major concern. It increases the morbidity and mortality of cardiovascular patients. The work was conducted to evaluate the adherence to cardiovascular medicines in patients of rural India.
The study was conducted in the Department of Medicine involving rural patients with essential hypertension (HTN), congestive cardiac failure (CCF), and ischemic heart disease (IHD) over 12 months period. Patients were prescribed with cardiovascular medicines at the initial visit and adherence to medicines was assessed in the subsequent visit. Four items Morisky's Medication Adherence Scale (MMAS-4) was used for assessing medication adherence. Patients were considered adherent to medication if they answered negatively to all four questions.
Overall adherence to medication was 20.83%, 28.37% and 32% in HTN, CCF, and IHD patients, respectively. Nonadherence was highest in patients of HTN. Among the four reasons of nonadherence assessed by MMAS-4, carelessness was the most common and forgetfulness was the least common cause of nonadherence in all the three groups of patients.
Patients of rural India adhere poorly to cardiovascular medicines. Nonadherence should be considered as a public health problem. Strategies for detecting the level of adherence of cardiovascular medicines, its barriers, and subsequent interventions should be developed by policy-makers to reduce morbidity and mortality due to cardiovascular disorders.
不坚持服用心血管药物是一个主要问题。它会增加心血管疾病患者的发病率和死亡率。本研究旨在评估印度农村地区患者对心血管药物的依从性。
该研究在医学系进行,为期12个月,纳入患有原发性高血压(HTN)、充血性心力衰竭(CCF)和缺血性心脏病(IHD)的农村患者。患者在初诊时开具心血管药物,并在随后的复诊中评估药物依从性。采用四项Morisky药物依从性量表(MMAS-4)评估药物依从性。如果患者对所有四个问题的回答均为否,则认为其坚持服药。
HTN、CCF和IHD患者的总体药物依从性分别为20.83%、28.37%和32%。HTN患者的不依从率最高。在MMAS-4评估的不依从的四个原因中,粗心是最常见的原因,而遗忘是所有三组患者中最不常见的不依从原因。
印度农村地区的患者对心血管药物的依从性较差。不依从应被视为一个公共卫生问题。政策制定者应制定检测心血管药物依从性水平、其障碍及后续干预措施的策略,以降低心血管疾病导致的发病率和死亡率。